Safe, effective, and available vaccines are the best long-term solution to the coronavirus pandemic.1 So it’s welcome news that two vaccines are poised for distribution and others will soon be on their way. Preliminary clinical trial data from these two vaccines, made by Pfizer and Moderna, indicate the vaccines are effective at stimulating a strong and long-lasting response against the virus responsible for COVID-19. A recent FDA briefing2 confirmed the efficacy and safety profile of Pfizer’s vaccine, reiterating the shot was 95 percent effective at preventing COVID-19 after two doses with no serious safety concerns.This is all good news, but it’s still unlikely that a vaccine will be widel
Read More Details
Finally We wish PressBee provided you with enough information of ( How to Build Trust in Covid-19 Vaccines - Issue 93: Forerunners )
Also on site :